Mastectomy, HER2 Receptor Positivity, NPI, Late Stage and Luminal B-Type Tumor as Poor Prognostic Factors in Geriatric Patients with Breast Cancer
<b>Background/Objectives:</b> This study aims to explore the risk factors associated with poor survival outcomes in geriatric female patients with breast cancer. <b>Methods:</b> This study utilized data from the METABRIC database to evaluate the risk factors associated with p...
Saved in:
Main Authors: | Demet Nak, Mehmet Kivrak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/15/1/13 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Low expression of TOX predicts poor prognosis of patients with breast cancer in the real world: A retrospective study
by: Chunlei Tan, et al.
Published: (2025-01-01) -
Development of prognostic models for HER2-positive metastatic breast cancer in females: a retrospective population-based study
by: Yan Chen, et al.
Published: (2024-12-01) -
SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer
by: Lutfi H. Alfarsi, et al.
Published: (2025-01-01) -
Impact of Comorbidities on Prognosis and Treatment Outcomes in Elderly Patients with Hodgkin Lymphoma
by: Dávid Tóthfalusi, et al.
Published: (2025-01-01) -
Subtype-specific prognostic impact of Bcl-2 in HER2-positive and HER2-negative breast cancer
by: Taeyeong Kim, et al.
Published: (2025-01-01)